How does Orthobiologics Work?

Approval of medical marijuana has been on a significant uptick in various states of the US, trailed by the legalization in Canada for both recreational and medicinal use recently.

The study estimates marijuana sales in 2019 to record a Y-o-Y growth at 9.3% over 2018.Request for the Report Summary: https://www.factmr.com/report/2032/controlled-substances-market“The Schedule of Controlled Substances currently positions marijuana in Schedule 1 – the most restrictive one reserved for “high potential for abuse,” “lack of accepted safety” and “no accepted medical use” drugs.

Attention deficit hyperactivity disorder (ADHD), and anxiety are other medical conditions wherein controlled substances are expected to witness promising future prospects, according to the study.Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S_id=2032The entrance of pharmaceutical giants in the cannabis sector of Canada alludes the next significant trend in the controlled substances industry, offering additional credibility to the sector.

Big pharmaceutical companies that eye collaborations and partnerships with cannabis producers having competitive differentiation circling their R initiatives, commercialization efforts, and clinical trial programs, are likely to witness significant revenue generation in the near future.

Ensuring effective and safe management of controlled drugs continues to remain an imperative agenda among pharmacists, which in turn has led the focus on fundamental changes including reviewing of liquid CD management and CD documentation to realize substantial improvements.

The pharmacists are also adhering to the operational standards, completely aware about the way CDs are managed, along with identifying potential drawbacks and reporting concerns regarding non-conformance.

Usages of these substances help to cure injuries rapidly.

As a result, the global orthobiologics market garners tremendous traction worldwide.Moreover, the massive consumption of orthobiologics in the healthcare sector for a range of medical applications and rising awareness towards the benefits of these materials accelerate market growth.

According to a leading research firm - Market Research Future (MRFR), the global orthobiologics market is projected to reach USD 4,964 MN by the end of 2019.

MRFR, in its recently publishes study report, also asserts that the market would register around 5.6% CAGR during the forecast period (2019–2024).Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/7826 Competitive AnalysisGlobus Medical Inc., Arthrex, Inc., Exactech, Inc., Johnson & Johnson, Wright Medical Group N.V., Zimmer Biomet, Medline Industries, Inc., Integra Life Sciences, Stryker Corporation, NuVasive, Inc., and others are some of the prominent names in the orthobiologics market.

The segmentation includes product, application, and end-user and they have been enriched by figures, charts, graphs, and others.By Product, the global market on the orthobiologics has been segmented into bone morphogenetic protein (BPM), synthetic bone substitutes, demineralized bone matrix (DBM), viscosupplementation products, allograft, and others.By Application, the global market study has been segmented on the basis of an understanding of segments like spinal fusion, soft tissue injuries, fracture recovery, osteoarthritis & degenerative arthritis, and others.

The spinal fusion segment was the dominant sector in 2018 as it was getting traction from spinal injuries from sports-related accidents, traumatic injuries, and accidents.By End user, the global report includes a proper study of segments like hospitals, orthopedic clinics, and others.Regional Analysis  North America dominates the global orthobiologics market, owing to the technological advancements, increasing funding & investments, and rising prevalence of bone injuries caused due to accidents.

According to the new market research report " Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) - Global Forecast to 2022", published by MarketsandMarkets™, The global orthobiologics market is expected to reach USD 6.06 Billion by 2022 from USD 4.44 Billion in 2016 at a CAGR of 5.4% during the forecast period.

Don’t miss out on business opportunities in Orthobiologics MarketBrowse and in-depth TOC on "Orthobiologics Market" 60  - Tables38  - Figures159  - PagesOrthobiologics Market : Years considered for the study are as followsBase Year: 2016Forecast Period: 2017–2022Orthobiologics Market : Objectives of the study areTo define, describe, and forecast the orthobiologics market on the basis of product, application, end user, and regionTo provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and challenges)To strategically analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the marketTo analyze the opportunities in the market for key stakeholders and provide details of the competitive landscape for major market leadersTo know about the assumptions considered for the study, download the pdf brochure This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market.

In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.As of 2016, Medtronic, DePuy Synthes, and Zimmer Biomet held the leading position in the market.

These companies adopted product launches, agreements, and partnerships as their business strategies in past three years to ensure market dominance.

Stryker, Bioventus, Harvest Technologies, Globus, Orthofix International, RTI Surgical, K2M Group, Kuros Biosciences, NuVasive, SeaSpine, and Xtant Medical are some of the other major players in this market.Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162747970Company InformationDetailed analysis and profiling of additional orthobiologics market players (up to 15)The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period.

Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the market.To speak to our analyst for a discussion on the above findings, click Speak to Analyst

The global orthobiologics market size was valued at USD 5.0 Billion in 2015 and is anticipated to reach USD 10.2 billion by 2025, with a CAGR of 7.5%.

Several merchants are forming strategic partnerships to diversify their businesses, grow their overall market share and spread out their product offerings.

These type of strategic alliances help the organizations to align their technologies with one another’s inventive medical device range.Download Free Sample Report @ https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sampleA growth in the global orthobiologics market is projected on account of the requirement for safer, more effective and modern orthopedic biologic treatment.

The bone graft procedure accounted to be the largest segment in the global orthobiologics market.The shifting preference to biological implants from mechanical implants is accelerating the growth of this market.

Another important trend that is estimated to enhance the growth of the market over next eight years is the increase in funds to improve orthobiologics.

The improvements in developing alternatives for pharmaceuticals, for making medical treatments more preventive than curative along with the country’s policy for decreasing the deficit in the budget is expected to negatively impact the global orthobiologics market.

10 Oct 2018 – This report studies Biological Implants Market Globally with SWOT analysis, Market Share, Segmentation, Insights, Growth, Application, Trends, Production, Revenue and Consumption analysis in these regions, forecast to 2024. Global Biological Implants Market is expected to reach USD 9.8 billion by 2024.

Biological Implants are termed as man-made medical devices developed to replace a missing biological structure, enhance an existing biological structure, or support a damaged biological structure.

The Biological Implants Market is estimated to grow at a significant CAGR of 7.6% over the forecast period as the scope and its applications are rising enormously across the globe.

Enhanced healthcare sector & modern infrastructure with the latest technology, growing awareness among populace regarding the advantages of biological implants, and growth in road accidents and sports injuries are documented as the major factors of Biological Implants Market that are expected to drive the growth in the years to come.

Looking into the global marketspace for controlled substances, Fact.MR has concluded some vital observations which highlights the burgeoning demand for such products.

According to this recently published study titled “Controlled Substances Market Forecast, Trend Analysis & Competition Tracking – Global Market Insights 2018 to 2028”, it has been revealed that growing preference for medical marijuana over prescription drugs to control headaches, back problems, depression and pain, despite criminalization, indicates current public health structure that believes cannabis moderation becoming outdated.

This assessment carefully unravels essential data associated to prime market specifics including market outlook, demand side trends, pipeline assessment, Y-o-Y growth trend analysis, forecast factors as well as market dynamics that comprise of drivers, opportunity and restraints.Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S_id=2032Popularity of Medical Marijuana Uplifting Investor Interest towards Controlled Substances It has been noticed that approval of medical marijuana has turned out to be a significant boost in various states of the US.

Such events have greatly contributed to the popularity of cannabis shares, together with efforts of leading controlled substance companies toward abolishing legal barriers as well as attracting investor interest.

For example, in Georgia, Florida and Michigan, the triggered preference as well as adoption of controlled substances for treating chronic and acute pain have enhanced.

In addition, attention deficit hyperactivity disorder (ADHD), as well as anxiety are some other medical conditions which are managed using controlled substance.

There’s an interesting new study,1 reported in the popular press last week,2 to the effect that people treated for moderate to severe psoriasis with a class of drugs called ‘biologics’ show improvement in coronary artery inflammation, a condition that’s associated with psoriasis.

Biologics are pharmaceutical products derived from biological sources.There’s a connection between psoriasis and arterial inflammation, in other words.Was anyone really surprised?Actually, no.

The data has been mounting for a long time, that psoriasis shares causal mechanisms and risk factors with a lot of other diseases, some of which might seem surprising, because they don’t appear as dermatology problems.This latest study is just more confirmation that psoriasis, a common chronic inflammatory disease of the skin, is really a systemic disorder, and quite a complex one, with health implications far beyond the skin.Psoriasis is not just another form of itchy rash, in other words, a bad dermatitis, that ought to be clearable with some sort of extra-strength cream.We don’t know what all the shared causal mechanisms are yet, with the other conditions that are associated with psoriasis, but we do know what a lot of those conditions are.3For instance, we’ve known for some time that psoriatic arthritis goes with psoriasis fairly frequently.

There is even a statistical connection between psoriasis and certain cancer malignancies, notably lymphoma.

It’s beginning to look like there might be associations between psoriasis and chronic obstructive pulmonary disease, for example, and with peptic ulcer disease.We speak of disease associations as ‘comorbidity’.

This is what we like to explain to patients who come for help with their psoriasis, and who sometimes find themselves frustrated by how long it takes before there’s an improvement.Treating psoriasis isn’t always as simple as putting on some cream.

Orthobiologics are derived from the human body and used by surgeons for treating injuries.

It helps in easy recovery and healing of wounds.

The surge in cases of trauma and sports injury, rising demand for biologics in minimally invasive procedures, increasing product approvals, and raising awareness are expected to drive the growth of the global orthobiologics market during the forecast period.Moreover, emerging technological inventions in biomaterials, growing obese and geriatric population, and increasing research and development activities by top players such as mergers, expansion, and collaboration for the development of new products and launches by major players are also boosting the growth of the market.

According to the report published by the Centers for Disease Control and Prevention (CDC), in 2016, 5.1% of men of 65 years and over are suffering from the lumbar spine in the US.

Also, 24.5% of women 65 years of age and over have a lumbar spine in US.The high costs associated with the orthobiologics, absence of proper reimbursement policies and scarcity of skilled workforce may hamper the growth of the market during the assessment period.Global Orthobiologics Market: Competitive LandscapeSome of the key players in the global Orthobiologics Market areArthrex, Inc.Exactech, Inc.Globus Medical Inc.Integra LifeSciencesJohnson & JohnsonMedline Industries, Inc.NuVasive, Inc.Stryker CorporationWright Medical Group N.V.Zimmer BiometOrthobiologics Market SegmentationThe global orthobiologics market has been segmented on the basis of product, application, end-user, and region.Based on product, the market has been classified as a Demineralized bone matrix (DBM), Bone morphogenetic protein (BPM), Allograft, Viscosupplementation products, Synthetic bone substitutes, and Others.Global orthobiologics market on the basis of application has been segmented into Osteoarthritis & degenerative arthritis, Spinal fusion, Fracture recovery, Soft tissue injuries, and Others.Based on end-user, the market has been segmented into Hospitals, Orthopedic Clinics, and Others.Orthobiologics Market Regional AnalysisThe market is likely to dominate by Americas during the forecast period owing to the well-established healthcare infrastructure, rising incidences of spinal disorders, obese and geriatric population, and preference for minimally invasive procedures.Europe is expected to be the second-largest market in the global orthobiologics market due to the rising adoption of newly introduced treatment procedures and technologies by a physician and patient awareness, government funding and support of the healthcare sector.The Asia-Pacific market is likely to hold a significant market share in the orthobiologics market.

The rising demand for advanced treatment, awareness and increasing investment in healthcare are responsible for the growth of this market in the region.The market in the Middle East & Africa is expected to account for the smallest share of the global orthobiologics market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.Table Of Content1.